Literature DB >> 17163597

Molecular mechanism of matrine-induced apoptosis in leukemia K562 cells.

Xiao-Shan Liu1, Jikai Jiang.   

Abstract

Matrine, a low toxic alkaloid purified from the Chinese herb Kushen, has been reported to induce apoptosis in leukemia K562 cells. In this study, the mechanism underling this apoptotic event was investigated. Treatment of K562 cells with matrine resulted in inhibition of cell survival more significantly than treatment of non-cancer fibroblast NIH3T3 cells. When K562 cells were incubated with matrine in higher than 0.2 mg/ml doses for 48 hours, the apoptotic cells were increased and both poly (ADP-ribose) polymerase (PARP) and caspase-3 were cleaved in a dose dependent manner. General caspase inhibitor (z-VAD-fmk) or caspase-3 inhibitor (z-DEVD-fmk) almost completely suppressed matrine-induced apoptosis. In addition, matrine increased proapoptotic protein bax and caused the release of cytochrome C. Taken together, the results suggest that matrine induces a cytochrome C-mediated, caspase-dependent apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17163597     DOI: 10.1142/S0192415X06004557

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  12 in total

1.  Matrine inhibits vascular smooth muscle cell proliferation by modulating the expression of cell cycle regulatory genes.

Authors:  Ping Zhu; Ji-mei Chen; Shu-zhen Chen; Cheng Zhang; Shao-yi Zheng; Guang Long; Ji Chen; Zhi-ling Zhou; Rui-xin Fan; Xiao-ping Fan; Yan-fang Chen; Jian Zhuang
Journal:  Acta Pharmacol Sin       Date:  2010-09-13       Impact factor: 6.150

2.  A study on isolation of chemical constituents from Sophora flavescens Ait. and their anti-glioma effects.

Authors:  Kebin Zheng; Chunhui Li; Xiaosong Shan; Haipeng Liu; Wufang Fan; Zhenshan Wang
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-11-02

3.  Matrine inhibits proliferation and induces apoptosis of human colon cancer LoVo cells by inactivating Akt pathway.

Authors:  Shujun Zhang; Binglin Cheng; Hali Li; Wei Xu; Bo Zhai; Shangha Pan; Lei Wang; Ming Liu; Xueying Sun
Journal:  Mol Biol Rep       Date:  2014-01-23       Impact factor: 2.316

4.  Effects of matrine on proliferation and apoptosis of cultured retinoblastoma cells.

Authors:  Bowen Zhao; Bin Li; Shuwei Bai; Ling Shen; Ruojin Ren; Jost B Jonas; Xiaolin Xu; Qingjun Lu; Qian Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-25       Impact factor: 3.117

5.  Matrine regulates immune functions to inhibit the proliferation of leukemic cells.

Authors:  Lei Zhang; Huizhang Zhang; Zhichao Zhu; Lijia Jiang; Xuzhang Lu; Min Zhou; Xiao Sun; Liuyang He; Yu Bai; Lingdi Ma
Journal:  Int J Clin Exp Med       Date:  2015-04-15

6.  Potential role of ginseng in the treatment of colorectal cancer.

Authors:  Chong-Zhi Wang; Chun-Su Yuan
Journal:  Am J Chin Med       Date:  2008       Impact factor: 4.667

7.  Matrine induces programmed cell death and regulates expression of relevant genes based on PCR array analysis in C6 glioma cells.

Authors:  Shujun Zhang; Jiping Qi; Libo Sun; Binglin Cheng; Shangha Pan; Min Zhou; Xueying Sun
Journal:  Mol Biol Rep       Date:  2008-04-08       Impact factor: 2.316

8.  Biopharmaceutical and pharmacokinetic characterization of matrine as determined by a sensitive and robust UPLC-MS/MS method.

Authors:  Zhen Yang; Song Gao; Taijun Yin; Kaustubh H Kulkarni; Yang Teng; Ming You; Ming Hu
Journal:  J Pharm Biomed Anal       Date:  2009-11-26       Impact factor: 3.935

9.  Matrine inhibits BCR/ABL mediated ERK/MAPK pathway in human leukemia cells.

Authors:  Lingdi Ma; Zhenyu Xu; Jian Wang; Zhichao Zhu; Guibin Lin; Lijia Jiang; Xuzhang Lu; Chang Zou
Journal:  Oncotarget       Date:  2017-11-10

10.  Antitumor activities of kushen: literature review.

Authors:  Mingyu Sun; Hongyan Cao; Lin Sun; Shu Dong; Yanqin Bian; Jun Han; Lijun Zhang; Shuang Ren; Yiyang Hu; Chenghai Liu; Lieming Xu; Ping Liu
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.